Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 29, 2006The FASEB Journal

Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice

View Full Paper
Ask AI
Bookmark
Share

Authors

LBLynsey G. BilslandWellcome Trust Centre for the History of MedicineJDJames R. DickUniversity of StirlingGPGareth PryceQueen Mary University of London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bilsland et al. (2006) studied this question.

synapsesocial.com/papers/6ab32312456ca0dc5f45ba4bhttps://doi.org/10.1096/fj.05-4743fje
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Blockade of cannabinoid CB<sub>1</sub> receptor function protects against <i>in vivo</i> disseminating brain damage following NMDA‐induced excitotoxicity2002 · 83 citations
  2. 2Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor2003 · 245 citations
  3. 3Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS2002 · 311 citations
  4. 4CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity2003 · 1,219 citations